Finance & Accounting Emerging Leaders Program (ELP) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Boston Scientific · 2 days ago

Finance & Accounting Emerging Leaders Program (ELP)

Boston Scientific is a leading medical technology company, and they are seeking participants for their Finance & Accounting Emerging Leaders Program (ELP). This three-day immersive leadership summit introduces rising juniors pursuing a degree in Accounting or Finance to the company's Finance organization, providing a comprehensive view of financial functions and corporate culture through development and networking opportunities.

Health CareMedicalMedical Device
badNo H1Bnote

Responsibilities

Engage with finance leaders and gain insights into their career journeys and leadership philosophies
Connect with professionals across diverse finance functions
Participate in interactive sessions focused on peer collaboration, problem-solving, and preparing for future opportunities
Experience our latest innovations and technologies firsthand
Learn about Boston Scientific’s mission, values, and strategic goals

Qualification

Accounting majorFinance majorMicrosoft ExcelLeadership experienceTeamwork experienceOrganization abilitiesInterest in healthcareCommunication skillsCollaboration skillsTime management

Required

Rising juniors with Accounting or Finance majors/ concentrations from an accredited college
Demonstrated leadership and teamwork experience
Proficiency in Microsoft Excel
Must be able to commit to dates of August 4-6, 2026
Must have reliable transportation to and from the Marlborough, MA, Boston Scientific location
Must be eligible to work in the U.S. without company sponsorship, now or in the future, for employment-based work authorization

Preferred

Strong communication and collaboration skills
Effective time management and organization abilities
Exhibit interest in accounting, finance, other business functions, and healthcare/medical technology

Company

Boston Scientific

company-logo
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.

Funding

Current Stage
Public Company
Total Funding
$10.02B
2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B

Leadership Team

leader-logo
Michael Mahoney
Chairman, President & CEO
linkedin
leader-logo
Daniel J. Brennan
Chief Financial Officer
linkedin
Company data provided by crunchbase